| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.0064 | 1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |